Side Effects Of Wegovy - Switch & Save Guide UK

Clinically Proven UK Registered Pharmacy

Cheapest Side Effects Of Wegovy Guide - UK Price £69.00

Understand Wegovy side effects at the cheapest UK price from £69.00 with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Understanding Side Effects Of Wegovy: Expert UK Guide

The side effects of Wegovy (semaglutide) are an important consideration for anyone starting or currently using this prescription weight loss treatment. As a UK-registered pharmacy with thousands of patient consultations completed, we've helped countless individuals navigate these effects whilst achieving their weight management goals. This comprehensive guide explains what to expect, how to manage common reactions, and when alternative treatments may be more suitable for your needs.

What Are The Most Common Side Effects Of Wegovy?

The side effects of Wegovy primarily affect the gastrointestinal system, as semaglutide works by slowing gastric emptying and affecting appetite-regulating hormones [1]. In the pivotal STEP clinical trials involving over 4,500 participants, the most frequently reported reactions included nausea (44% of participants), diarrhoea (30%), vomiting (24%), constipation (24%), and abdominal pain (20%) [1]. These effects typically emerge during dose escalation and tend to diminish as your body adapts to the medication.

Most patients experience mild to moderate gastrointestinal side effects of Wegovy during the first 8-12 weeks of treatment, particularly when increasing to higher doses [2]. The structured dose escalation schedule—starting at 0.25mg weekly and gradually increasing to the maintenance dose of 2.4mg—is specifically designed to minimise these reactions. Our clinical team at Cured Pharmacy monitors patient progress throughout treatment, with superintendent pharmacist Tarun Kumar (GPhC 2233073) ensuring appropriate support is provided at each stage.

Beyond gastrointestinal effects, some patients report headaches (14%), fatigue (11%), and dizziness (8%) as side effects of Wegovy [1]. Injection site reactions such as redness, itching, or mild swelling occur in approximately 5% of users but are generally transient and resolve without intervention. Serious adverse events are rare but include potential risks of pancreatitis, gallbladder problems, and hypoglycaemia in patients taking certain diabetes medications concurrently.

How Wegovy's Mechanism Causes Side Effects

Understanding why the side effects of Wegovy occur helps patients manage them more effectively. Semaglutide is a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a hormone naturally produced in the intestine [2]. By activating GLP-1 receptors throughout the gastrointestinal tract, Wegovy slows the movement of food from the stomach to the small intestine, which directly contributes to feelings of fullness but also explains the nausea and digestive discomfort many patients experience. This delayed gastric emptying is therapeutic for weight loss but requires dietary adjustments to minimise adverse reactions.

Managing The Side Effects Of Wegovy: Practical Strategies

Successfully managing the side effects of Wegovy often determines treatment adherence and long-term success. Our clinical experience with thousands of UK patients has identified several evidence-based strategies that significantly reduce gastrointestinal discomfort. Eating smaller, more frequent meals rather than three large meals helps accommodate the slower gastric emptying, whilst avoiding high-fat, fried, or heavily spiced foods reduces nausea triggers [3]. Staying well-hydrated with at least 2 litres of water daily helps prevent constipation and supports overall tolerance.

Timing your Wegovy injection consistently each week and taking it after a light meal rather than on an empty stomach can minimise the side effects of Wegovy for many patients [3]. If nausea persists, ginger tea, peppermint, or anti-nausea medication (prescribed separately if appropriate) may provide relief. For constipation, increasing dietary fibre gradually through vegetables, fruits, and whole grains, alongside gentle movement or walking, typically resolves the issue within days. Our prescribers at Cured Pharmacy can adjust your escalation schedule if side effects become problematic, sometimes extending time at a lower dose before progressing.

Monitoring for serious side effects of Wegovy requires awareness of warning signs that necessitate immediate medical attention. Severe, persistent abdominal pain radiating to the back may indicate pancreatitis; sudden vision changes warrant ophthalmological review; and symptoms of gallbladder disease including jaundice or clay-coloured stools require urgent assessment [2]. These serious events are rare, occurring in less than 1% of clinical trial participants, but patient vigilance combined with regular clinical review ensures early detection and appropriate management.

Comparing Side Effects Of Wegovy With Alternative Treatments

When the side effects of Wegovy prove intolerable despite management strategies, understanding alternative weight loss medications becomes essential. Mounjaro (tirzepatide), available at Cured Pharmacy from £69.00, is a dual GIP/GLP-1 receptor agonist that demonstrated superior weight loss outcomes in head-to-head trials but with a similar gastrointestinal side effect profile [4]. In the SURPASS-2 trial, tirzepatide users experienced nausea rates of 21-33% depending on dose, compared to 18% with semaglutide 1mg, suggesting comparable tolerability [4].

For patients seeking to avoid the common side effects of Wegovy entirely, non-GLP-1 alternatives present different tolerability profiles. Orlistat (from £69.00 at Cured Pharmacy) works by blocking fat absorption in the intestine, causing different gastrointestinal effects including oily stools and flatulence, but no nausea or delayed gastric emptying [5]. Mysimba (naltrexone/bupropion combination, from £69.00) acts on the central nervous system to reduce appetite, with side effects including headache, insomnia, and dry mouth rather than gastrointestinal disturbance [5]. Each medication requires individual assessment by a UK prescriber to determine suitability based on your medical history and tolerance.

Wegovy Oral Tablets: A Different Side Effect Profile

The newly available Wegovy oral tablets (semaglutide pill, from £69.00) offer an alternative delivery method that may alter the side effects of Wegovy for some patients. Whilst the active ingredient remains semaglutide, oral administration requires higher doses to achieve equivalent blood levels due to gastrointestinal breakdown, and preliminary data suggests potentially different tolerability patterns [6]. Some patients who experienced significant injection-related anxiety or injection site reactions with subcutaneous Wegovy find the oral formulation more acceptable, though gastrointestinal side effects remain the primary concern with both delivery methods.

Treatment Primary Side Effects Mechanism Starting Price
Wegovy (Semaglutide) Injection Nausea, diarrhoea, vomiting, constipation GLP-1 receptor agonist from £89.00
Wegovy Oral Tablets Similar GI effects, no injection site reactions GLP-1 receptor agonist (oral) from £83.00
Mounjaro (Tirzepatide) Nausea, diarrhoea, decreased appetite Dual GIP/GLP-1 agonist from £145.00
Saxenda (Liraglutide) Nausea, vomiting, diarrhoea, constipation GLP-1 receptor agonist from £68.00
Orlistat Oily stools, flatulence, bowel urgency Lipase inhibitor from £32.00
Mysimba Headache, insomnia, dry mouth, nausea Naltrexone/bupropion combination from £125.95

When To Consider Switching From Wegovy Due To Side Effects

Deciding when the side effects of Wegovy warrant switching to an alternative treatment requires balancing efficacy against tolerability. If gastrointestinal symptoms persist beyond 12 weeks at a stable dose, significantly impact quality of life, or prevent dose escalation to the therapeutic 2.4mg maintenance level, switching may optimise your weight management journey [3]. Our clinical team evaluates each case individually—sometimes a temporary dose reduction or treatment pause allows symptoms to resolve before resuming, whilst other situations benefit from transitioning to a medication with a different mechanism of action.

The side effects of Wegovy should be weighed against the substantial weight loss benefits demonstrated in clinical trials, where participants lost an average of 15% of their body weight over 68 weeks [1]. However, if you're experiencing inadequate weight loss alongside troublesome side effects, or if you've developed contraindications such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, switching becomes medically necessary. Cured Pharmacy's transparent pricing and comprehensive weight loss portfolio—including Mounjaro, Saxenda, Orlistat, Xenical, Alli, Orlos, and Mysimba—ensures you can access the most suitable alternative without delay, subject to prescriber approval.

Long-Term Side Effects Of Wegovy: What The Evidence Shows

Understanding the long-term side effects of Wegovy requires examining extended clinical trial data and post-marketing surveillance. The STEP trials followed participants for up to 104 weeks, revealing that whilst gastrointestinal side effects typically diminish after the initial months, some patients experience persistent but mild nausea or altered bowel habits throughout treatment [1]. Importantly, no new safety signals emerged with prolonged use, and the medication's cardiovascular benefits—demonstrated in the SELECT trial showing 20% reduction in major adverse cardiovascular events—provide additional therapeutic value beyond weight loss [7].

Potential long-term side effects of Wegovy include changes in heart rate (average increase of 1-4 beats per minute), possible effects on thyroid function requiring monitoring, and rare cases of diabetic retinopathy worsening in patients with pre-existing diabetes [2]. The MHRA continues to monitor semaglutide safety data across all licensed indications, with healthcare professionals required to report suspected adverse reactions through the Yellow Card scheme. At Cured Pharmacy, we ensure patients receive regular clinical review throughout extended treatment, with our UK-registered prescribers assessing ongoing suitability every 3-6 months as recommended by NICE guidance.

Pregnancy, Breastfeeding And Wegovy Side Effects

The side effects of Wegovy during pregnancy and breastfeeding require special consideration, as semaglutide is not recommended for use during these periods [2]. Animal studies showed potential reproductive toxicity, and the medication should be discontinued at least 2 months before planned conception to allow adequate washout. Women who become pregnant whilst taking Wegovy should stop immediately and contact their prescriber. Similarly, it's unknown whether semaglutide passes into breast milk, so breastfeeding mothers should discuss alternative weight management approaches with their healthcare provider. Our clinical team at Cured Pharmacy screens for pregnancy and breastfeeding status during every consultation to ensure safe prescribing practices.

Accessing Wegovy And Managing Side Effects With Cured Pharmacy

At Cured Pharmacy, we provide comprehensive support for patients navigating the side effects of Wegovy throughout their weight loss journey. Our UK-registered clinical team, led by superintendent pharmacist Tarun Kumar (GPhC 2233073), conducts thorough online consultations taking under 3 minutes, ensuring Wegovy is clinically appropriate before prescribing. We offer Wegovy from £69.00—among the most competitive UK pricing—with transparent costs displayed before consultation, and £20 off your first order using code Weightlossnew. All medications are UK-licensed and dispensed from our GPhC-registered premises (9012511), with 100% discreet packaging and next-day delivery options available.

Managing the side effects of Wegovy effectively requires ongoing clinical support, which our team provides through accessible telephone consultations (+44 116 4646009) and follow-up assessments. If side effects prove problematic, we can facilitate switching to alternative treatments from our comprehensive weight loss portfolio, including Mounjaro (from £69.00), Wegovy oral tablets (from £69.00), Saxenda (from £69.00), or non-GLP-1 options like Orlistat (from £69.00), Xenical (from £69.00), Alli (from £69.00), Orlos (from £69.00), or Mysimba (from £69.00). Each transition requires fresh clinical assessment by a UK prescriber, ensuring your safety and optimising treatment outcomes whilst maintaining the lowest UK prices guaranteed.

Scientific References

  1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. [accessed 15 August 2026]
  3. Kushner, R. F., Calanna, S., Davies, M., Dicker, D., Garvey, W. T., Goldman, B., ... & Wilding, J. P. (2020). Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5. Obesity, 28(6), 1050-1061. [accessed 15 August 2026]
  4. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 15 August 2026]
  5. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE guideline. [accessed 15 August 2026]
  6. Knop, F. K., Aroda, V. R., do Vale, R. D., Holst-Hansen, T., Laursen, P. N., Rosenstock, J., ... & OASIS 1 Investigators. (2023). Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 402(10403), 705-719. [accessed 15 August 2026]
  7. Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., ... & SELECT Trial Investigators. (2023). Semaglutide and cardiovascular outcomes in obesity without diabetes. New England Journal of Medicine, 389(24), 2221-2232. [accessed 15 August 2026]
  8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long do the side effects of Wegovy typically last?
Most side effects of Wegovy, particularly gastrointestinal symptoms like nausea and diarrhoea, peak during the first 8-12 weeks of treatment and gradually diminish as your body adapts. Many patients find symptoms significantly improve after reaching a stable maintenance dose.
Can I take anti-nausea medication to manage Wegovy side effects?
Yes, anti-nausea medications can be prescribed separately to help manage the side effects of Wegovy if dietary modifications prove insufficient. Discuss options with your prescriber, as some medications may interact or affect Wegovy's absorption.
Are the side effects of Wegovy worse at higher doses?
Side effects of Wegovy typically intensify during dose escalation periods, which is why the medication uses a gradual titration schedule starting at 0.25mg weekly. Staying at each dose level for 4 weeks before increasing allows your body to adapt and minimises adverse reactions.
What are the serious side effects of Wegovy I should watch for?
Serious side effects of Wegovy requiring immediate medical attention include severe abdominal pain (possible pancreatitis), vision changes, symptoms of gallbladder disease, severe allergic reactions, or signs of thyroid tumours such as neck lumps or persistent hoarseness. These occur rarely but warrant urgent assessment.
Do Wegovy side effects differ from Mounjaro side effects?
The side effects of Wegovy and Mounjaro are similar as both affect GLP-1 receptors, causing comparable gastrointestinal reactions. Mounjaro also activates GIP receptors, which may slightly alter the side effect profile, though clinical trials show similar overall tolerability between the two medications.
Will the side effects of Wegovy go away if I reduce my dose?
Temporarily reducing your Wegovy dose often alleviates side effects whilst maintaining therapeutic benefit. Your prescriber can adjust your treatment schedule, extending time at a lower dose before re-attempting escalation, ensuring you reach the optimal maintenance dose with acceptable tolerability.
Can I switch from Wegovy to another weight loss treatment if side effects persist?
Yes, if the side effects of Wegovy remain problematic despite management strategies, switching to an alternative treatment with a different mechanism—such as Orlistat, Mysimba, or continuing with a GLP-1 option like Saxenda—is possible subject to clinical assessment by a UK prescriber.
Are Wegovy oral tablets better for avoiding side effects than injections?
Wegovy oral tablets eliminate injection site reactions and may suit patients with needle anxiety, but the core side effects of Wegovy related to GLP-1 activation—particularly gastrointestinal symptoms—remain similar between oral and injectable formulations as both deliver semaglutide systemically.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.